|
Orwin Says Affymax Entering $2 Billion Dialysis Market - Washington Post |
|
|
Washington Post
June 27 (Bloomberg) -- John Orwin, chief executive officer of Affymax Inc., talks about the company's efforts to secure FDA approval for its first product, a drug used in the treatment of kidney dialysis patients with anemia. Orwin also discusses drug
|
|
Dialysis Patient Uses Treatment Time To Teach - LocalNews8.com |
|
|
LocalNews8.com
IDAHO FALLS, Idaho -- Having to rely on dialysis for kidney function is life-changing, as it requires dozens of hours each week spent plugged into a machine. But one Idaho Falls man has found a way to give back with the extra time.
|